Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · IEX Real-Time Price · USD
0.720
-0.025 (-3.38%)
May 31, 2024, 4:00 PM EDT - Market closed
Xtant Medical Holdings Revenue
Xtant Medical Holdings had revenue of $101.23M in the twelve months ending March 31, 2024, with 60.81% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $27.87M with 55.34% year-over-year growth. In the year 2023, Xtant Medical Holdings had annual revenue of $91.30M with 57.50% growth.
Revenue (ttm)
$101.23M
Revenue Growth
+60.81%
P/S Ratio
0.93
Revenue / Employee
$489,043
Employees
207
Market Cap
93.76M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 91.30M | 33.33M | 57.50% |
Dec 31, 2022 | 57.97M | 2.71M | 4.90% |
Dec 31, 2021 | 55.26M | 1.93M | 3.61% |
Dec 31, 2020 | 53.34M | -11.35M | -17.54% |
Dec 31, 2019 | 64.68M | -7.52M | -10.42% |
Dec 31, 2018 | 72.20M | -10.41M | -12.60% |
Dec 31, 2017 | 82.61M | -7.39M | -8.21% |
Dec 31, 2016 | 90.00M | 30.66M | 51.66% |
Dec 31, 2015 | 59.35M | 24.01M | 67.97% |
Dec 31, 2014 | 35.33M | 2.26M | 6.83% |
Dec 31, 2013 | 33.07M | 93.52K | 0.28% |
Dec 31, 2012 | 32.98M | 2.83M | 9.39% |
Dec 31, 2011 | 30.15M | 14.73M | 95.55% |
Dec 31, 2010 | 15.42M | 8.02M | 108.53% |
Dec 31, 2009 | 7.39M | 6.93M | 1,509.98% |
Dec 31, 2008 | 459.23K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Aurora Cannabis | 200.73M |
SCYNEXIS | 140.39M |
Precision BioSciences | 57.53M |
Eton Pharmaceuticals | 35.30M |
KORU Medical Systems | 29.32M |
Elutia | 28.99M |
ProPhase Labs | 28.72M |
MSP Recovery | 9.71M |
XTNT News
- 18 days ago - Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance - Accesswire
- 25 days ago - Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 - Accesswire
- 4 weeks ago - Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds - GlobeNewsWire
- 2 months ago - Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million - GlobeNewsWire
- 2 months ago - Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 - GlobeNewsWire
- 3 months ago - Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial - GlobeNewsWire
- 3 months ago - Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 7 months ago - Xtant Medical to Participate in Upcoming Investor Conferences - GlobeNewsWire